<SEC-DOCUMENT>0001104659-25-002258.txt : 20250110
<SEC-HEADER>0001104659-25-002258.hdr.sgml : 20250110
<ACCEPTANCE-DATETIME>20250110064035
ACCESSION NUMBER:		0001104659-25-002258
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250110

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TriSalus Operating Life Sciences, Inc.
		CENTRAL INDEX KEY:			0001518906
		ORGANIZATION NAME:           	
		IRS NUMBER:				270629393
		STATE OF INCORPORATION:			CO
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-94792
		FILM NUMBER:		25520282

	BUSINESS ADDRESS:	
		STREET 1:		6272 WEST 91ST AVENUE
		CITY:			WESTMINSTER
		STATE:			CO
		ZIP:			80031
		BUSINESS PHONE:		(888) 321-5212

	MAIL ADDRESS:	
		STREET 1:		6272 WEST 91ST AVENUE
		CITY:			WESTMINSTER
		STATE:			CO
		ZIP:			80031

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TriSalus Life Sciences, Inc.
		DATE OF NAME CHANGE:	20211001

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Surefire Medical, Inc.
		DATE OF NAME CHANGE:	20110425

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lombard International Assurance S.A.
		CENTRAL INDEX KEY:			0001767788
		ORGANIZATION NAME:           	
		IRS NUMBER:				981273128
		STATE OF INCORPORATION:			N4
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G

	BUSINESS ADDRESS:	
		STREET 1:		4, RUE LOU HEMMER
		CITY:			FINDEL
		STATE:			N4
		ZIP:			1748
		BUSINESS PHONE:		00352346191502

	MAIL ADDRESS:	
		STREET 1:		4, RUE LOU HEMMER
		CITY:			FINDEL
		STATE:			N4
		ZIP:			1748
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Lombard International Assurance S.A. -->
          <cik>0001767788</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>12/30/2024</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001518906</issuerCik>
        <issuerName>TriSalus Life Sciences Inc.</issuerName>
        <issuerCusip>89680M101</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>6272 W. 91st Ave.</com:street1>
          <com:city>Westminster</com:city>
          <com:stateOrCountry>CO</com:stateOrCountry>
          <com:zipCode>80031</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(b)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Lombard International Assurance S.A.</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>N4</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>0.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>0</classPercent>
      <typeOfReportingPerson>FI</typeOfReportingPerson>
      <comments>Lombard International Assurance S.A. was acquired by Utmost Group PLC on 30/12/2024. Shareholdings of Lombard International Assurance S.A. were disclosed on 21/10/2024, accession number 0001104659-24-110077</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>TriSalus Life Sciences Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>6272 W. 91st Ave. Westminster, CO, 80031</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Lombard International Assurance S.A.</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>4, rue Lou Hemmer L-1748 Luxembourg</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Luxembourg</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>N</notApplicableFlag>
        <typeOfPersonFiling>FI</typeOfPersonFiling>
        <otherTypeOfPersonFiling>an insurance undertaking or reinsurance undertaking authorized in accordance with Directive 2009/138/EC</otherTypeOfPersonFiling>
      </item3>
      <item4>
        <amountBeneficiallyOwned>0 shares</amountBeneficiallyOwned>
        <classPercent>0.00</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>0</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>None</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>0</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>None</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>N</notApplicableFlag>
        <classOwnership5PercentOrLess>Y</classOwnership5PercentOrLess>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to (J) A non-U.S. institution that is the functional equivalent of any of the institutions listed in SS240.13d-1 (b)(1)(ii)(A) through (I), so long as the non-U.S. institution is subject to a regulatory scheme that is substantially comparable to the regulatory scheme applicable to the equivalent U.S. institution is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Lombard International Assurance S.A.</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Nadine Provost</signature>
        <title>Nadine Provost - Director of Investment Administration</title>
        <date>01/06/2025</date>
      </signatureDetails>
      <signatureDetails>
        <signature>/s/ Thierry Leung</signature>
        <title>Thierry Leung - Director - Head of Fund Administration</title>
        <date>01/06/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
